Hormone Muscle Increase Steroid API Material Powder CAS 10161-34-9 for Bodybuilding and Fitness

CAS 10161-34-9 Usage:

CAS10161-34-9 is a short-acting trenbolone, which is a derivative, it will not be converted into estrogen, but it will have the side effects of progesterone (similar to estrogen side effects). Has certain liver toxicity. Trenbolone can rapidly increase muscle strength and size, and improve muscle mass. Accelerates fat burning and is one of the most powerful endosterols. Not suitable for beginners, very suitable for fat loss or during competition preparation. CAS10161-34-9 is an injectable (generic) anabolic steroid derived from. However, its activity is identical to that of its structural parent, so direct comparisons between the two are difficult. CAS10161-34-9 is a non-estrogen steroid that is more anabolic and androgenic per mg than. In terms of appearance, it is comparable to androgens such as nostrotone, but more common than. It is estimated to be approximately three times more androgenic than testosterone, making it one of the strongest injectable anabolic steroids commercially manufactured. Among athletes, this steroid is highly valued for its ability to increase muscle stiffness, raw strength, without unnecessary increases in water retention and fat mass. It is considered the drug of choice for competitive bodybuilders and remains popular with those who simply want to improve their physical fitness.
CAS10161-34-9 is a modified form of. It differs by the introduction of a double bond at carbons 9 and 11, which inhibits aromatization (9-ene), increases androgen binding affinity, and slows down its metabolism. The resulting steroid has a stronger anabolic and androgenic effect than. CAS10161-34-9 contains chemokines modified by the addition of a carboxylate (acetic acid) to the 17-beta hydroxyl group, allowing for a slow release of free steroid in the injected area.
Although classified as an anabolic steroid, CAS10161-34-9 is still sufficiently androgenic. Androgenic side effects are very common with this drug and may include oily skin, acne, and onset of body/facial hair growth. Anabolic/androgenic steroids may also worsen male pattern baldness. Women are also warned by of the potential pathogenic effects of anabolic/androgenic steroids. These may include deepening of the voice, menstrual irregularities, changes in skin texture, facial hair growth, and clitoral enlargement. In addition,CAS10161-34-9 cannot be metabolized by 5-alpha reductase, so its relative androgenicity is not affected.